Followers | 369 |
Posts | 5333 |
Boards Moderated | 1 |
Alias Born | 05/09/2013 |
Wednesday, February 14, 2018 3:27:57 PM
It's not diluted like a subpenny stock & even those can have short term breaks in dilution to pave opportunity for trading.
I was smart enough to wait until after it announced prior share offerings to raise cash before adding NVCN to my Watch List & haven't posted about it until today's new lows under .30.
This will take a break in the dilution at some point & will be a good bouncer. Most of these biotech stocks that don't make profits have dilution, but are trade-able.
The dilution affect on these types of stock is standard base-line knowledge for traders to trade through.
I stick by what I said earlier that we probably saw short term bottom today. There was a lot of volume (above normal) that put it to .26 low earlier after it had already been very oversold, setting up an increased chance of a capitulation threshold forming.
...We'll see later if I'm right. I'm not always 100% right (and no one is). I just think we're close to capitulation in the short term.
***Go to my 'Profile' for more information on following me***
Recent NVCN News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/03/2023 04:15:07 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM